Notably, CD3+, CD4, and CD8+ TILs were shown to secret pro-inflammatory cytokines and suppress tumor growth, whereas cancer cells were found to produce CCL18, which increases migration of regulatory T cells to tumor sites and promotes tumor progression. This evidence concerns the gene CD8A and neoplasm.